Flagship explainer
What drives VYNE THERAPEUTICS INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$26.5M | FY2025 |
| |
| Income before tax | −$26.7M | FY2025 |
|
| Operating income | −$29.7M | FY2025 |
|
| $570000 | FY2025 |
| |
| Ending assets | $30.2M | FY2025 |
|
| Beginning assets | $66.9M | FY2024 |
|
| $27.8M | FY2025 |
| |
| $52.1M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001566044-26-000002
- SEC filingFiling detailsAccession 0001628280-25-010908